Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cdk4 inhibitor'

Search results for: 'cdk4 inhibitor'

Items 11-20 of 35

Page
per page
  1. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL
  2. PHA-793887
    A5459 PHA-793887
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Pan-Cdk inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  3. Mitoxantrone HCl
    B2114 Mitoxantrone HCl
    Target: Pim|Topoisomerases|USP|HIV Integrases
    Summary: Topoisomerase II inhibitor, anti-neoplastic drug
      insoluble in EtOH; ≥51.53 mg/mL
  4. Nu 6027
    A1986 Nu 6027
    Target: Cyclin-Dependent Kinases|ATM/ATR
    Summary: ATR/CDK inhibitor, potent and selective
      insoluble in H2O; ≥12.55 mg/mL
  5. Etoposide
    A1971 Etoposide
     4 Citation
    Target: Topoisomerases
    Summary: Topo II inhibitor
      ≥29.45 mg/mL
  6. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
  7. MK-8776 (SCH-900776)
    A8477 MK-8776 (SCH-900776)
    Target: Chk
    Summary: Chk1 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥18.8 mg/mL
  8. TAE226 (NVP-TAE226)
    A8557 TAE226 (NVP-TAE226)
     1 Citation
    Target: FAK
    Summary: FAK inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL
  9. LDE225 (NVP-LDE225,Erismodegib)
    B2266 LDE225 (NVP-LDE225,Erismodegib)
     1 Citation
    Target: Smoothened
    Summary: Smoothened inhibitor,potent and selective
      ≥24.3 mg/mL
  10. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor

Items 11-20 of 35

Page
per page